Expanding Orthopedics was granted its 14th U.S. Patent, covering 3D expandable cage technology integrated in the FLXfit™. Specifically, the patent addresses the multiple segment design with its articulation mechanism, and the angular expansion for dial-in lordosis correction.
FLXfit received CE Mark Approval and FDA 510(k) clearance in 2014, with initial procedures occurring within the same year.
Sources: Expanding Orthopedics, Inc.; ORTHOWORLD Inc.
Expanding Orthopedics was granted its 14th U.S. Patent, covering 3D expandable cage technology integrated in the FLXfit™. Specifically, the patent addresses the multiple segment design with its articulation mechanism, and the angular expansion for dial-in lordosis correction.
FLXfit received CE Mark Approval and FDA 510(k)...
Expanding Orthopedics was granted its 14th U.S. Patent, covering 3D expandable cage technology integrated in the FLXfit™. Specifically, the patent addresses the multiple segment design with its articulation mechanism, and the angular expansion for dial-in lordosis correction.
FLXfit received CE Mark Approval and FDA 510(k) clearance in 2014, with initial procedures occurring within the same year.
Sources: Expanding Orthopedics, Inc.; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.